17 articles for H Mazdiyasni
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Ka.

Celgene Avilomics Research
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors.

Abbott Laboratories
Hydroxamic acid inhibitors of 5-lipoxygenase.

TBA
Novel IKK inhibitors: beta-carbolines.

Millennium Pharmaceuticals
Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.

Agouron Pharmaceuticals
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase.

Abbott Laboratories
Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.

Abbott Laboratories
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis.

Abbott Laboratories
Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships.

Abbott Laboratories
Imidazole and triazole containing bicyclic compounds as JAK inhibitors

Theravance Biopharma R&D Ip
Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative

Institute of Materia Medica, Chinese Academy of Medical Sciences
Carboxamide derivatives useful as rsk inhibitors

Phoenix Molecular Designs
Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Department Of Health and Human Services
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof

Guangzhou Maxinovel Pharmaceuticals
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

Lycera
Protein kinase C inhibitors and methods of their use

Novartis
Trk-inhibiting compound

Ono Pharmaceutical